NiuSan , most of them are like small retail investors, just invest in stocks, buy low and sell high to get returns. There are a few bulls who covet the controlling rights of listed companies and are optimistic about listed companies, so they start to raise their shares in the secondary market. There are many conditions for raising a leasing in the secondary market. First, there must be sufficient capital scale; second, listed companies have the value of leasing and their business is stable; third, the shares held by major shareholders are not too large and their control is not strong, etc. Niu San Gao Yaping raised the mercenary of the listed company Jinshi Yayao at the right time and successfully promoted to the largest shareholder.
Gao Yaping is the founder, chairman and famous investor of Qianzhan and Yarui Capital, and a master of Peking University Advanced Business Administration EMBA. has long been engaged in investment and financial services in stocks, futures , equity and other aspects. It has institutional cooperation and integration platform resources covering the entire financial system and industry. It has rich successful experience in the integration of financial and financial products, direct fund investment, mature risk control system and post-investment value-added services.
Jinshi Asia Pharmaceutical is its main business for the research and development and manufacturing of medical health and special equipment technology. The company's main products include complete production lines, mechanical accessories and other, health products, cracks, etc. The crack product has been launched in the 1990s. After years of development, the "crack" series of cold medicines have become a household name in China and have won the honor of the national "famous trademark". In 2021, the operating income and profits were 1.054 billion yuan and 56.76 million yuan, respectively, an increase of 35.53% and 109.67% respectively over the same period last year. In the first quarter of 2022, the operating income and profits were 315 million and 63.28 million, respectively, a decrease of 16.42% and 15.62% respectively compared with the same period last year.
Hao Yaping holds Jinshi Sub-Pharmaceutical stock changes
Niu San Gao Yaping invested in Jinshi Sub-Pharmaceutical earlier. In 2018, Gao Yaping entered Jinshi Sub-Pharmaceutical. In May of that year, Gao Yaping spent 351 million yuan to acquire 8.19% of the shares of Jinshiya Pharmaceutical shareholders Chen Shaojiang and Ji Yuchuan into Jinshiya Pharmaceutical. At the same time, it also acquired 4% of the shares through bulk transactions. After this operation, Gao Yaping directly became the second largest shareholder of Jinshi Asia Pharmaceutical. In the more than a year after that, Gao Yaping did not move much.
Jinshi Asia Pharmaceutical's 2019 annual report shows that as of the end of the reporting period, Gao Yaping's shareholding ratio was still 12.19%. Since then, Niu San Gao Yaping once again increased her holdings of more than 1% through the secondary market. As of the end of the third quarter of 2020, Gao Yaping's holdings of 53.245 million shares, a proportion rising to 13.25%, ranking second largest shareholder and close to the largest shareholder. In September of the same year, Gao Yaping signed a "Share Transfer Agreement" with Xie Shihuang, Chen Shaojiang and Zhi Ruoyu, respectively, and acquired a total of 20.0903 million shares in the form of through agreement, accounting for 5% of the company's total share capital. Gao Yaping directly held 18.25% of the total shares of Jinshi Yaya Pharmaceutical, which exceeded the shareholding ratio of Kuai Yixi, the founder of Jinshi Yaya Pharmaceutical. is already the single largest shareholder of Jinshi Yaya Pharmaceutical. On September 16, 2021, Kuai Yixi and Yang Xiaodong transferred 5.10% of their shares to Gao Yaping for an agreement of RMB 169.53 million. The shareholding ratio of Niu San Gao Yaping further increased to 25.11%, and the position of the largest shareholder became more stable.
Jinshi Asia Pharmaceutical Stock Price Trend Chart
Jinshi Asia Pharmaceutical's stock price has not performed very well since its listing. Gao Yaping's investment and holding stocks should be relatively high, and it is still in a floating loss. To transform from an investor to an industrialist, this requires the transformation of Niu San Gao Yaping's identity. The company's market value will increase in the later stage depends on the improvement of the company's performance. These will face various challenges for Gao Yaping, who comes from the secondary market.
In addition to holding the bid for Jinshi Asian Medicine, Niu San Gao Yaping also holds stocks of other listed companies. Let’s take a look.
Stock | Stock | Stock meter (10,000 shares) | Market value | accounts for the total circulating shares | shareholding changes | Total market value (billion) | ||||
| 08.61 | ||||||||||
| .143% | .143% | unchanged html l3 | 0201 quarterly | |||||||
9.37 | 018 | |||||||||
| hheideman | 60.1 | |||||||||
| unchanged | 0.41 | 020 4th quarter | |||||||
Meriyun | 147.29 | .18 | .65% | unchanged |
| Q16 | ||||
Qianjiang Motorcycle | 392.81 | .74 | unchanged |
| 016 quarter 2 | |||||
Hailanxin |
Increase holdings
2.27
02.23
Keliyuan
.11
unchanged
Total holding market value html l3
data ended on March 31, 2022
Niu San Gao Yaping holds a total of 8 stocks, with a total market value of 1.873 billion. Except for Jinshi Yaya Pharmaceutical, which is the largest shareholder, the shareholding ratio of other stocks is less than 5%. However, its holdings have been very long, even nearly 10 years. For example, Keliyuan has increased its holdings since its establishment in the fourth quarter of 2013, and has not adjusted the position for a total of 18 quarters.
Keliyuan, was established in January 1998. It is an international high-tech enterprise integrating advanced energy storage materials, advanced batteries, electric vehicle energy package, hybrid powertrain system and its extended products. It is committed to building a full industrial chain in the fields of energy conservation and new energy. The company was listed on Shanghai Stock Exchange in September 2003. In 2021, the operating income and profits were RMB 3.058 billion and RMB 16.24 million, respectively, an increase of 20.14% and -23.95% over the same period last year. In the first quarter of 2022, the company's operating income and profit were RMB 541 million and RMB 23.71 million, respectively, an increase of 11.76% and 169.93% respectively over the same period last year. With the recent explosion of stock prices in the automotive industry, the company's stock price has also hit a new high, reaching 9.20 yuan, and the company's market value is 15.28 billion yuan.Niu San Gaoyaqin's stock profit is more than 100 million.
Keli Long-term stock price trend chart
Qianjiang Motorcycle, Niu San Gaoyaqin started to invest and build positions in the second quarter of 2016, the positions can be divided into three parts.
Gaoyaqin Investment's shareholding shareholding changes in Qianjiang Motorcycle shares
From the second quarter of 2016 to the third quarter of 2017, it has been increasing its holdings, increasing its holdings from 3.48 million shares to 13.92 million shares, with a shareholding ratio of 3.07%. The second phase is from the fourth quarter of 2017 to the third quarter of 2020, and the number of shares has not changed during this period. The third quarter is from the fourth quarter of 2020 to the present, and the number of stocks has undergone a small change, with the shareholding ratio changing between 3.05% and 3.07%, with little change. Qianjiang Motorcycle's stock price is currently at a relatively high point. The Niu San Gaoyiqin should have a floating profit of more than twice.
Qianjiang Motorcycle Stock Price Trend Chart
This article involves content related to listed companies, and is a personal analysis and judgment made by the author based on the information disclosed by the listed company based on its legal obligations; it does not constitute any investment or transaction proposal, and it does not assume any responsibility for any actions arising from the adoption of this article. Investment is risky, and you need to be cautious when trading stocks!
